Claris Advisors’s Hologic HOLX Stock Holding History

Claris Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8	Closed	-$652	–	540
2024 Q3	$652	Buy	+8	New	+$640	﹤0.01%	556

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Claris Advisors's HOLX Position: Q4 2024 in Review

Claris Advisors sold out of Hologic (HOLX) in Q4 2024, closing a stake of 8 shares — an estimated $652 sold.

Claris Advisors first reported a position in HOLX in Q3 2024 and held it in 1 quarter. The position peaked at $652 in Q3 2024. 719 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

Claris Advisors reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
Claris Advisors sold 8 Hologic shares in Q4 2024, an estimated $652.
Claris Advisors first reported a position in Hologic in Q3 2024 and held it in 1 quarter.
Claris Advisors's Hologic position peaked at $652 in Q3 2024.
719 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.